Dynamics of a class of immune networks. I. Global stability of idiotype interactions.

F. Varela,J. Stewart

DOI: https://doi.org/10.1016/S0022-5193(05)80301-7

IF: 2.405

1990-05-10

Journal of Theoretical Biology

Abstract:

What problem does this paper attempt to address?

Brain Imaging for Stroke

Jin Cao,Min Lou

DOI: https://doi.org/10.1007/978-981-10-5804-2_6

2017-01-01

Abstract:Brain imaging (neuroradiology) is a subspecialty of radiology. Benefiting from the newly emerging radiological techniques, neuroradiology has greatly broadened our understanding on diagnosis, characterization, and mechanism of central nervous diseases, especially stroke. Brain reperfusion therapy is the most convincing treatment in acute ischemic stroke. It is of great importance to prudently select patients potentially benefiting from reperfusion therapy and minimize reperfusion injuries, not only in clinical practice but also in demanding insights from basic research. Neuroradiology is thereby a bridge translating basic research results to clinical applications, and clinical neuroradiological findings could in turn help to apprehend underlying disease mechanism. In this chapter, we are going to discuss the main neuroradiological advances on translational research in stroke. Firstly, we introduce basic radiological methods and techniques for stroke research briefly. Then, we discuss the core concept in stroke imaging: penumbra and collateral vessel imaging, which are important characteristics in patient selection for reperfusion therapy. Finally, we talk about the reperfusion injury and introduce some useful radiological markers.
Imaging Markers in Acute Phase of Stroke: Implications for Prognosis

Ying Zhou,Sheng Zhang,Min Lou

DOI: https://doi.org/10.1016/j.hest.2019.12.002

2020-01-01

Brain Hemorrhages

Abstract:Currently, various methods for inspecting ischemic stroke are available, especially the imaging techniques, which play an important role in assisting diagnosis and prognostication of ischemic stroke. In the acute phase of ischemic stroke, however, there still lack of well-established imaging markers that could reliably predict patients’ functional outcome. We thus reviewed literatures focusing on relevant imaging markers of ischemic tissue, intra-arterial thrombus, arterial collateral circulation, draining veins and functional connectivity, which may be valuable to evaluate the initial severity of stroke in the acute phase of ischemic stroke and predict neurological outcome in the long term.
Validating a Predictive Model of Acute Advanced Imaging Biomarkers in Ischemic Stroke

Andrew Bivard,Christopher Levi,Longting Lin,Xin Cheng,Richard Aviv,Neil J. Spratt,Min Lou,Tim Kleinig,Billy O'Brien,Kenneth Butcher,Jingfen Zhang,Jim Jannes,Qiang Dong,Mark Parsons

DOI: https://doi.org/10.1161/strokeaha.116.015143

IF: 10.17

2017-01-01

Stroke

Abstract:Background and Purpose— Advanced imaging to identify tissue pathophysiology may provide more accurate prognostication than the clinical measures used currently in stroke. This study aimed to derive and validate a predictive model for functional outcome based on acute clinical and advanced imaging measures. Methods— A database of prospectively collected sub-4.5 hour patients with ischemic stroke being assessed for thrombolysis from 5 centers who had computed tomographic perfusion and computed tomographic angiography before a treatment decision was assessed. Individual variable cut points were derived from a classification and regression tree analysis. The optimal cut points for each assessment variable were then used in a backward logic regression to predict modified Rankin scale (mRS) score of 0 to 1 and 5 to 6. The variables remaining in the models were then assessed using a receiver operating characteristic curve analysis. Results— Overall, 1519 patients were included in the study, 635 in the derivation cohort and 884 in the validation cohort. The model was highly accurate at predicting mRS score of 0 to 1 in all patients considered for thrombolysis therapy (area under the curve [AUC] 0.91), those who were treated (AUC 0.88) and those with recanalization (AUC 0.89). Next, the model was highly accurate at predicting mRS score of 5 to 6 in all patients considered for thrombolysis therapy (AUC 0.91), those who were treated (0.89) and those with recanalization (AUC 0.91). The odds ratio of thrombolysed patients who met the model criteria achieving mRS score of 0 to 1 was 17.89 (4.59–36.35, P<0.001) and for mRS score of 5 to 6 was 8.23 (2.57–26.97, P<0.001). Conclusions— This study has derived and validated a highly accurate model at predicting patient outcome after ischemic stroke.
Ciri After Early Recanalization

Qingmeng Chen,Min Lou

DOI: https://doi.org/10.1007/978-3-319-90194-7_4

2018-01-01

Abstract:Even with rapid reperfusion therapy for acute ischemic stroke, there is still a potential risk of clinical deterioration, such as cerebral hemorrhage, infarct growth or brain edema after early recanalization, which is so-called "reperfusion injury". Blood-brain barrier (BBB) damage, inflammatory responses and leukocyte recruitment are believed as main pathophysiological mechanisms. With the development of neuroimage, several novel neuroimaging markers had been reported. Hyperintense acute reperfusion marker (HARM) and quantitative methods including Patlak algorithm, relative recirculation (rR) on enhanced neuroimage can evaluate the damage of BBB, which may induce cerebral hemorrhage. Postischemic hyperperfusion and "no-reflow phenomenon", which correlate with infarct growth, are observed on perfusion image. Ischemic conditioning therapy, immunosuppressive agents and hypothermia treatment may have potential therapeutic values in future.
Endovascular Therapy in Acute Ischemic Stroke: Time is Brain

An-Li WANG,Zhi-Cai CHEN,Fei-Na SHI,Min LOU

DOI: https://doi.org/10.3969/j.issn.1673-5765.2018.02.012

2018-01-01

Abstract:Endovascular therapy brings a breakthrough progress in treatment of ischemic patients with acute large artery occlusion. Recent years studies have shown that endovascular therapy is more highly time-dependent than intravenous thrombolysis in terms of clinical outcome. To reduce reperfusion time delay is important for the management and development of endovascular therapy. Optimization of emergency rescue work flow, utilization of rapid and effective imaging evaluation system and development of fast recanalization method of thrombectomy will be helpful in clinical promotion and application of endovascular therapy in treatment of acute ischemic stroke.
Effect of Imaging Markers on Reperfusion Therapy in Basilar Artery Occlusion

Shenqiang Yan,Ying Zhou,Yuqi Zhao,Feng Wang,Anyang Tao,Lin Zhou,Mengxiong Pan,Genlong Zhong,Lingzhi Hu,Xuanfei Jiang,Xinlei Mao,Huan Tang,Jianwei Wang,Shuxia Qian,Jingping Sun,Xiaoxian Gong,Wansi Zhong,Min Lou

DOI: https://doi.org/10.1002/ana.26376

IF: 11.2

2022-01-01

Annals of Neurology

Abstract:ObjectiveWe aimed to investigate the effectiveness of endovascular therapy (EVT) versus intravenous thrombolysis (IVT) in patients with basilar artery occlusion (BAO), based on the information of advanced imaging.MethodsWe analyzed data of stroke patients with radiologically confirmed BAO within 24 hours. BAO subjects were categorized into “top‐of‐the‐basilar” syndrome (TOBS) and other types. An initial infarct size of <70ml and a ratio of ischemic tissue to infarct volume of ≥1.8 was defined as “target mismatch.” The primary outcome was a good outcome, defined as a modified Rankin Scale score of 0 to 3 at 3 months. Propensity score adjustment and inverse probability of treatment weighting (IPTW) propensity score methods were used.ResultsAmong 474 BAO patients, 93 (19.6%) were treated with IVT prior to EVT, 91 (19.2%) were treated with IVT alone, 95 (20.0%) were treated with EVT alone, and 195 (41.1%) were treated with antithrombotic therapy. In IPTW analyses, we found no benefit of EVT over IVT for good outcome in either TOBS patients (odds ratio = 1.08, 95% confidence interval [CI] = 0.88–1.31) or those with other types (odds ratio = 1.13, 95% CI = 0.94–1.36). However, in patients with other types, if there existed a target mismatch, EVT was independently related to good outcome (odds ratio = 1.46, 95% CI = 1.17–1.81).InterpretationThe “target mismatch profile” seems to be a possible candidate selection standard of EVT for those with other types of BAO. Future studies should separate TOBS from other types of BAO, and try to use advanced imaging. ANN NEUROL 2022;92:97–106
Perfusion Computed Tomography in Patients with Stroke Thrombolysis.

Hiroyuki Kawano,Andrew Bivard,Longting Lin,Henry Ma,Xin Cheng,Richard Aviv,Billy O'Brien,Kenneth Butcher,Min Lou,Jingfen Zhang,Jim Jannes,Qiang Dong,Christopher R. Levi,Mark W. Parsons

DOI: https://doi.org/10.1093/brain/aww338

IF: 14.5

2016-01-01

Brain

Abstract:Stroke shortens an individual's disability-free life. We aimed to assess the relative prognostic influence of pre-and post-treatment perfusion computed tomography imaging variables (e.g. ischaemic core and penumbral volumes) compared to standard clinical predictors (such as onset-to-treatment time) on long-term stroke disability in patients undergoing thrombolysis. We used data from a prospectively collected international, multicentre, observational registry of acute ischaemic stroke patients who had perfusion computed tomography and computed tomography angiography before treatment with intravenous alteplase. Baseline perfusion computed tomography and follow-up magnetic resonance imaging were analysed to derive the baseline penumbra volume, baseline ischaemic core volume, and penumbra salvaged from infarction. The primary outcome measure was the effect of imaging and clinical variables on Disability-Adjusted Life Year. Clinical variables were age, sex, National Institutes of Health Stroke Scale score, and onset-to-treatment time. Age, sex, country, and 3-month modified Rankin Scale were extracted from the registry to calculate disability-adjusted life-year due to stroke, such that 1 year of disability-adjusted life-year equates to 1 year of healthy life lost due to stroke. There were 772 patients receiving alteplase therapy. The number of disability-adjusted life-year days lost per 1 ml of baseline ischaemic core volume was 17.5 (95% confidence interval, 13.2-21.9 days, P < 0.001). For every millilitre of penumbra salvaged, 7.2 days of disability-adjusted life-year days were saved (beta = -7.2, 95% confidence interval, -10.4 to -4.1 days, P < 0.001). Each minute of earlier onset-to-treatment time resulted in a saving of 4.4 disability-free days after stroke (1.3-7.5 days, P = 0.006). However, after adjustment for imaging variables, onset-to-treatment time was not significantly associated with savings in disability-adjusted life-year days. Pretreatment perfusion computed tomography can (independently of clinical variables) predict significant gains, or loss, of disability-free life in patients undergoing reperfusion therapy for stroke. The effect of earlier treatment on disability-free life appears explained by salvage of penumbra, particularly when the ischaemic core is not too large.
From “Time is Brain” to “Imaging is Brain”: A Paradigm Shift in the Management of Acute Ischemic Stroke

Josep Puig,Jai Shankar,David Liebeskind,Mikel Terceño,Kambiz Nael,Andrew M Demchuk,Bijoy Menon,Dar Dowlatshahi,Carlos Leiva‐Salinas,Max Wintermark,Götz Thomalla,Yolanda Silva,Joaquin Serena,Salvador Pedraza,Marco Essig

DOI: https://doi.org/10.1111/jon.12693

2020-02-10

Journal of Neuroimaging

Abstract:Arterial recanalization to restore the blood supply and limit the brain damage is the primary goal in the management of acute ischemic stroke (AIS). Since the publication of pivotal randomized clinical trials in 2015, endovascular thrombectomy has become part of the standard of care in selected cases of AIS from large-vessel occlusions up to 6 hours after the onset of symptoms. However, the association between endovascular reperfusion and improved functional outcome is not strictly time dependent. Rather than on rigid time windows, candidates should be selected based on vascular and physiologic information. This approach places imaging data at the center of treatment decisions. Advances in imaging-based management of AIS provide crucial information about vessel occlusion, infarct core, ischemic penumbra, and degree of collaterals. This information is invaluable in identifying patients who are likely to benefit from reperfusion therapies and excluding those who are unlikely to benefit or are at risk of adverse effects. The approach to reperfusion therapies continues to evolve, and imaging is acquiring a greater role in the diagnostic work-up and treatment decisions as shown in recent clinical trials with extended time window. The 2018 American Heart Association/American Stroke Association guidelines reflect a paradigm shift in the management of AIS from "Time is Brain" to "Imaging is Brain." This review discusses the essential role of multimodal imaging developing from recent trials on therapy for AIS.

radiology, nuclear medicine & medical imaging,clinical neurology,neuroimaging
Neuroimaging of Acute Ischemic Stroke: Multimodal Imaging Approach for Acute Endovascular Therapy

Mohamad Abdalkader,James E. Siegler,Jin Soo Lee,Shadi Yaghi,Zhongming Qiu,Xiaochuan Huo,Zhongrong Miao,Bruce C.V. Campbell,Thanh N. Nguyen

DOI: https://doi.org/10.5853/jos.2022.03286

2023-04-07

Journal of Stroke

Abstract:Advances in acute ischemic stroke (AIS) treatment have been contingent on innovations in neuroimaging. Neuroimaging plays a pivotal role in the diagnosis and prognosis of ischemic stroke and large vessel occlusion, enabling triage decisions in the emergent care of the stroke patient. Current imaging protocols for acute stroke are dependent on the available resources and clinicians

peripheral vascular disease,clinical neurology
Thrombolysis for pulmonary embolism in patients with right ventricular dysfunction: con.

G. Thabut,D. Logeart

DOI: https://doi.org/10.1001/ARCHINTE.165.19.2200

2005-10-24

Archives of Internal Medicine

Abstract:A LTHOUGH THE MORtality rate for those with acute PE is low, certain patients are at high risk. Therefore, optimal management strategies should rely on risk stratification rather than “one-size-fits-all” treatment. In high-risk patients, the use of aggressive treatment could be justified. Despite the lack of definitive evidence, massive PE associated with cardiogenic shock, given the high mortality rate, is a widely accepted indication for thrombolysis. At the other extreme, the risks of thrombolysis are not justified in patients with an anatomically small PE that causes no elevation in RV afterload. The mortality rate for these patients is low, with most patients dying from underlying conditions rather than from PE. In a metaanalysis of 5 studies involving 1302 patients with PE treated by heparin followed by warfarin, the rate of death due to PE was only 1.5%. In such patients, the expected improvement in survival would be offset by the risk of life-threatening or disabling hemorrhage with thrombolytic treatment. The core of the thrombolysis debate focuses on hemodynamically stablepatientswithPEandsomeform of RV dysfunction. Because 30% to 50% of patients with PE present with echocardiographic evidence of RV dysfunction, the administration of a thrombolytic treatment toallof them would have significant implications. The arguments for thrombolysis in such patients are essentially the following:(1)RVdysfunctionisastrong prognostic factor in patients with acute PE; (2) the ability of thrombolytic agents to improve pulmonary reperfusionandenhanceRVfunction should translate into clinical benefit; and(3) resultsof several studieshave suggestedabeneficialeffectof thrombolysis in patients with acute PE and RV dysfunction. However, a more thoroughappraisalof thecurrentevidence does not support such conclusions. The following is based on a systematic review of the literature, whereby MEDLINE records from 1966 to 2004 were searched with the terms thrombolytictherapy, thrombolysis, fibrinolysis, thromboembolism, and pulmonary embolism to identify all studies evaluating thrombolytic therapy for PE.
Abstract 106: Novel Imaging-based Morphological Markers For Improved Prediction Of Stroke Outcomes: A Machine Learning Approach

Kaveh Laksari,Aditi Deshpande,Max Wintermark,Bin Jiang,Pouya Tahsili-Fahadan,Chelsea S Kidwell,Jordan Elliot

DOI: https://doi.org/10.1161/str.54.suppl_1.106

IF: 10.17

2023-02-01

Stroke

Abstract:Patient selection for acute reperfusion therapies of acute ischemic stroke is based on assessment of the core and tissue-at-risk and the time from stroke onset. Response to treatment and clinical outcomes, however, vary significantly since patient-specific cerebrovascular anatomy plays a vital role in governing flow and reperfusion. We developed an end-to-end automated machine learning approach to extract advanced cerebrovascular morphological features, including tortuosity and collateral index, to improve outcome prediction, and patient selection. Methods: Using our validated automatic cerebrovascular segmentation and feature extraction algorithm, we obtained the morphological properties of the brain vasculature, including vessel tortuosity, length, diameter, and bifurcation patterns, in MR angiography scans of 100 anonymized stroke patients. Each patient’s collateral index was also automatically graded using a previously established probabilistic atlas of healthy cerebrovasculature. To predict 90-day functional outcomes (mRS), a statistical model was trained using patients' clinical features (demographics, comorbidities, and baseline NIHSS), imaging features (initial ASPECTS, perfusion mismatch volume, and collateral index), and the extracted morphologic features (length, diameter, number of branches, vessel tortuosity, fractal dimension, and total volume). The predictions were compared against ground truth mRS to assess model accuracy. We also compared the model’s performance against conventional outcome predictors with only the clinical and imaging features. Results: The conventional model including the common clinical and imaging features excluding the collateral index gave an area under the curve (AUC) of 0.63, which is comparable to previously published results. Including the automatically scored collateral index improved the accuracy to 0.74. We found that further including the morphological features to the predictor model significantly improved AUC accuracy to 0.83. Conclusion: Including automatically extracted cerebrovascular morphologic features in traditional clinical and imaging markers significantly improves outcome prediction and response to treatment in stroke patients.

peripheral vascular disease,clinical neurology
recent advances in imaging of acute ischemic stroke

Amr Ahmed Kandeel,Mahitab Ghonim,Ashraf Shoma,Amr kandeel,mahitab ghonim

DOI: https://doi.org/10.21608/mjmu.2021.84209.1030

2022-04-01

Mansoura Medical Journal

Abstract:The need for early accurate diagnosis of AIS has motivated the development of new advanced imaging techniques for the early diagnosis of the condition and the selection of patients who might present outside the window for systemic thrombolytic therapy. During the last decade, the state of art imaging techniques has developed for the imaging of patients with hyperacute stroke including both angiographic and perfusion imaging. The imaging modalities, which are in widespread use in primary stroke imaging include; computed tomography and magnetic resonance imaging. Imaging can be categorized into structural imaging, vascular imaging and perfusion imaging. Important signs of early stroke on brain CT include; insular ribbon sign, the hypedense artery sign, and the development of hypo-attenuation lesions. MRI is more sensitive than CT for the demonstration of these lesions especially diffusion weighted images which are currently the gold standard for the evaluation of the extent of infarct core. Susceptibility weighted images are highly sensitive for the demonstration of hyperacute bleed within the infarct. CT and MR angiography are highly sensitive for the demonstration of large vessel occlusion which is very important for selection of patients for endovascular treatment. Perfusion studies can be performed using CT or MRI and are showing an increasing role in the identification of salvageable brain tissue (penumbra) and target mismatch between hypoperfused volume and infarct core, an important criterion for selection of patient who might benefit from endovascular treatment.
Neuronal plasma biomarkers in acute ischemic stroke

Julia K Gundersen,Fernando Gonzalez-Ortiz,Thomas Karikari,Bjørn-Eivind Kirsebom,Katrin Mertes,Henrik Zetterberg,Hlin Kvartsberg,Ole Morten Rønning,Berglind Gísladóttir,Kaj Blennow,Tormod Fladby

DOI: https://doi.org/10.1177/0271678x241293537

2024-10-27

Journal of Cerebral Blood Flow & Metabolism

Abstract:Journal of Cerebral Blood Flow &Metabolism, Ahead of Print. Early imaging-based detection of acute ischemic stroke (AIS) has improved in the era of reperfusion therapy. Despite of this, prognosis of outcome after AIS remains a challenge. Therefore, parameters that support clinical decision making are sought. Blood-based biomarkers have the potential to provide valuable information in addition to the established prognostic factors. Neuronal biomarkers of acute or degenerative neuronal injury have shown to be reliably detected in plasma. These biomarkers are well-established in neurodegenerative pathology, such as Alzheimer's disease. In this study, we explored the association between stroke diameter and plasma biomarkers for neuronal injury and tau pathophysiology (brain-derived tau [BD-tau], phosphorylated-tau-217 [p-tau21] and neurofilament light [NfL]) in patients (n = 193) admitted to the acute ward, Akershus University Hospital. All patients received a final diagnosis of AIS, transient ischemic attack or stroke mimics. Blood samples were obtained the day after admission. We find that levels of BD-tau (p = .004) and NfL (p = .011) were higher after AIS than in patients with stroke mimics. The cortical stroke diameter correlated with BD-tau (tau-b = 0.64, p < .001) and p-tau217 (tau-b = 0.36, p = .003). Linear regression confirmed BD-tau to be the strongest variable associated with stroke diameter, pointing to the potential clinical value of plasma BD-tau in outcome prediction after AIS.

neurosciences,endocrinology & metabolism,hematology
Advanced Imaging for Acute Stroke Treatment Selection: CT, CTA, CT Perfusion, and MR Imaging

Robert W Regenhardt,Christopher A Potter,Samuel S Huang,Michael H Lev

DOI: https://doi.org/10.1016/j.rcl.2023.01.003

Abstract:There is constant evolution in the diagnosis and treatment of acute ischemic stroke due to advances in treatments, imaging, and outreach. Two major revolutions were the advent of intravenous thrombolysis in the 1990s and endovascular thrombectomy in 2010s. Neuroimaging approaches have also evolved with key goals-detect hemorrhage, augment thrombolysis treatment selection, detect arterial occlusion, estimate infarct core, estimate viable penumbra, and augment thrombectomy treatment selection. The ideal approach to diagnosis and treatment may differ depending on the system of care and available resources. Future directions include expanding indications for these treatments, including a shift from time-based to tissue-based selection.
Imaging Biomarkers of Vulnerable Carotid Plaques for Stroke Risk Prediction and Their Potential Clinical Implications.

Luca Saba,Tobias Saam,H Rolf Jäger,Chun Yuan,Thomas S Hatsukami,David Saloner,Bruce A Wasserman,Leo H Bonati,Max Wintermark

DOI: https://doi.org/10.1016/s1474-4422(19)30035-3

IF: 59.935

2019-01-01

The Lancet Neurology

Abstract:Stroke represents a massive public health problem. Carotid atherosclerosis plays a fundamental part in the occurence of ischaemic stroke. European and US guidelines for prevention of stroke in patients with carotid plaques are based on quantification of the percentage reduction in luminal diameter due to the atherosclerotic process to select the best therapeutic approach. However, better strategies for prevention of stroke are needed because some subtypes of carotid plaques (eg, vulnerable plaques) can predict the occurrence of stroke independent of the degree of stenosis. Advances in imaging techniques have enabled routine characterisation and detection of the features of carotid plaque vulnerability. Intraplaque haemorrhage is accepted by neurologists and radiologists as one of the features of vulnerable plaques, but other characteristics-eg, plaque volume, neovascularisation, and inflammation-are promising as biomarkers of carotid plaque vulnerability. These biomarkers could change current management strategies based merely on the degree of stenosis.
Imaging Selection for Reperfusion Therapy in Acute Ischemic Stroke

Jeremy J. Heit,Max Wintermark

DOI: https://doi.org/10.1007/s11940-014-0332-3

IF: 2

2015-01-27

Current Treatment Options in Neurology

Abstract:Opinion statementNeuroimaging is essential in the evaluation of the acute stroke patient. Computed tomography (CT) or magnetic resonance imaging (MRI) should be used to confirm the diagnosis of acute stroke, exclude stroke mimics, and triage patients for intravenous tissue plasminogen activator and endovascular revascularization therapies. Advanced neuroimaging techniques, including CT-angiography, MR-angiography, CT-perfusion, and MR-perfusion should be used to further inform acute stroke treatment decisions. Patients considered for endovascular stroke therapy should have (1) a vascular occlusion that can be reached by an endovascular approach; (2) a small area of core cerebral infarction; and (3) viable tissue at risk of infarction if prompt revascularization is not achieved (penumbra).

clinical neurology
Brain ischemia: CT and MRI techniques in acute ischemic stroke

Pedro Vilela,Howard A. Rowley

DOI: https://doi.org/10.1016/j.ejrad.2017.08.014

IF: 4.531

2017-11-01

European Journal of Radiology

Abstract:Imaging plays a central role for intravenous and intra-arterial arterial ischemic stroke treatment patient selection. Computed tomography (CT) / CT angiography or magnetic resonance (MR) / MR angiography imaging are used to exclude stroke mimics and haemorrhage, to determine the cause and mechanism of stroke, to define the extension of brain infarct and to identify the arterial occlusion. Imaging may identify the patients that will be benefit more from revascularization therapies independently of the conventional therapeutic time window allowing individualized treatment decisions and improving individual patient outcome. Multiparametric CT/MR imaging may be used to identify the extension of potential viable brain tissue (penumbra) and of irreversible brain lesion (core) using CT perfusion and/or diffusion weighed and perfusion weighted MR imaging. The status of the arterial collateral circulation and the type and extension of the clot may be assessed by imaging. The accuracy and the clinical significance for treatment and patient clinical outcome of different imaging techniques are reviewed.

radiology, nuclear medicine & medical imaging
Molecular biomarkers in stroke diagnosis and prognosis

Matthew B Maas,Karen L Furie

DOI: https://doi.org/10.2217/bmm.09.30

2009-08-01

Biomarkers in Medicine

Abstract:Serum biomarkers related to the cascade of inflammatory, hemostatic, glial and neuronal perturbations have been identified to diagnose and characterize intracerebral hemorrhage and cerebral ischemia. Interpretation of most markers is confounded by their latent rise, blood–brain barrier effects, the heterogeneity of etiologies and the wide range of normal values, limiting their application for early diagnosis, lesion size estimation and long-term outcome prediction. Certain hemostatic and inflammatory constituents have been found to predict response to thrombolysis and worsening due to infarct progression and secondary hemorrhage, offering a potential role for improved treatment selection and individualization of therapy. Biomarkers will become increasingly relevant for developing targets for neuroprotective therapies, monitoring response to treatment and as surrogate end points for treatment trials.

medicine, research & experimental
Acute ischemic stroke biomarkers: a new era with diagnostic promise?

Shadi Bsat,Adham Halaoui,Firas Kobeissy,Charbel Moussalem,Mohamad Nabih El Houshiemy,Sarah Kawtharani,Ibrahim Omeis

DOI: https://doi.org/10.1002/ams2.696

2021-01-01

Abstract:Stroke is considered as the first cause of neurological dysfunction and second cause of death worldwide. Recombinant tissue plasminogen activator is the only chemical treatment for ischemic stroke approved by the US Food and Drug Administration. It was the only standard of care for a long time with a very narrow therapeutic window, which usually ranges from 3 to 4.5 h of stroke onset; until 2015, when multiple trials demonstrated the benefit of mechanical thrombectomy during the first 6 h. In addition, recent trials showed that mechanical thrombectomy can be beneficial up to 24 h if the patients meet certain criteria including the presence of magnetic resonance imaging/computed tomography perfusion mismatch, which allows better selectivity and higher recruitment of eligible stroke patients. However, magnetic resonance imaging/computed tomography perfusion is not available in all stroke centers. Hence, physicians need other easy and available diagnostic tools to select stroke patients eligible for mechanical thrombectomy. Moreover, stroke management is still challenging for physicians, particularly those dealing with patients with "wake-up" stroke. The resulting brain tissue damage of ischemic stroke and the subsequent pathological processes are mediated by multiple molecular pathways that are modulated by inflammatory markers and post-transcriptional activity. A considerable number of published works suggest the role of inflammatory and cardiac brain-derived biomarkers (serum matrix metalloproteinase, thioredoxin, neuronal and glial markers, and troponin proteins) as well as different biomarkers including the emerging roles of microRNAs. In this review, we assess the accumulating evidence regarding the current status of acute ischemic stroke diagnostic biomarkers that could guide physicians for better management of stroke patients. Our review could give an insight into the roles of the different emerging markers and microRNAs that can be of high diagnostic value in patients with stroke. In fact, the field of stroke research, similar to the field of traumatic brain injury, is in immense need for novel biomarkers that can stratify diagnosis, prognosis, and therapy.
Utilizing imaging parameters for functional outcome prediction in acute ischemic stroke: A machine learning study

Burak B. Ozkara,Mert Karabacak,Meisam Hoseinyazdi,Samir A. Dagher,Richard Wang,Sadik Y. Karadon,F. Eymen Ucisik,Konstantinos Margetis,Max Wintermark,Vivek S. Yedavalli

DOI: https://doi.org/10.1111/jon.13194

2024-03-04

Journal of Neuroimaging

Abstract:Background and Purpose We aimed to predict the functional outcome of acute ischemic stroke patients with anterior circulation large vessel occlusions (LVOs), irrespective of how they were treated or the severity of the stroke at admission, by only using imaging parameters in machine learning models. Methods Consecutive adult patients with anterior circulation LVOs who were scanned with CT angiography (CTA) and CT perfusion were queried in this single‐center, retrospective study. The favorable outcome was defined as a modified Rankin score (mRS) of 0‐2 at 90 days. Predictor variables included only imaging parameters. CatBoost, XGBoost, and Random Forest were employed. Algorithms were evaluated using the area under the receiver operating characteristic curve (AUROC), the area under the precision‐recall curve (AUPRC), accuracy, Brier score, recall, and precision. SHapley Additive exPlanations were implemented. Results A total of 180 patients (102 female) were included, with a median age of 69.5. Ninety‐two patients had an mRS between 0 and 2. The best algorithm in terms of AUROC was XGBoost (0.91). Furthermore, the XGBoost model exhibited a precision of 0.72, a recall of 0.81, an AUPRC of 0.83, an accuracy of 0.78, and a Brier score of 0.17. Multiphase CTA collateral score was the most significant feature in predicting the outcome. Conclusions Using only imaging parameters, our model had an AUROC of 0.91 which was superior to most previous studies, indicating that imaging parameters may be as accurate as conventional predictors. The multiphase CTA collateral score was the most predictive variable, highlighting the importance of collaterals.

radiology, nuclear medicine & medical imaging,clinical neurology,neuroimaging

Dynamics of a class of immune networks. I. Global stability of idiotype interactions.

Brain Imaging for Stroke

Imaging Markers in Acute Phase of Stroke: Implications for Prognosis

Validating a Predictive Model of Acute Advanced Imaging Biomarkers in Ischemic Stroke

Ciri After Early Recanalization

Endovascular Therapy in Acute Ischemic Stroke: Time is Brain

Effect of Imaging Markers on Reperfusion Therapy in Basilar Artery Occlusion

Perfusion Computed Tomography in Patients with Stroke Thrombolysis.

From “Time is Brain” to “Imaging is Brain”: A Paradigm Shift in the Management of Acute Ischemic Stroke

Neuroimaging of Acute Ischemic Stroke: Multimodal Imaging Approach for Acute Endovascular Therapy

Thrombolysis for pulmonary embolism in patients with right ventricular dysfunction: con.

Abstract 106: Novel Imaging-based Morphological Markers For Improved Prediction Of Stroke Outcomes: A Machine Learning Approach

recent advances in imaging of acute ischemic stroke

Neuronal plasma biomarkers in acute ischemic stroke

Advanced Imaging for Acute Stroke Treatment Selection: CT, CTA, CT Perfusion, and MR Imaging

Imaging Biomarkers of Vulnerable Carotid Plaques for Stroke Risk Prediction and Their Potential Clinical Implications.

Imaging Selection for Reperfusion Therapy in Acute Ischemic Stroke

Brain ischemia: CT and MRI techniques in acute ischemic stroke

Molecular biomarkers in stroke diagnosis and prognosis

Acute ischemic stroke biomarkers: a new era with diagnostic promise?

Utilizing imaging parameters for functional outcome prediction in acute ischemic stroke: A machine learning study